Financials data is unavailable for this security.
View more
Year on year Arvee Laboratories (India) Ltd 's revenues fell -50.54% from 613.47m to 303.45m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 41.19m to 10.52m, a -74.46% decrease.
| Gross margin | 48.21% |
|---|---|
| Net profit margin | 4.52% |
| Operating margin | 6.11% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Arvee Laboratories (India) Ltd increased its cash reserves by 244.23%, or 13.13m. The company earned 36.64m from its operations for a Cash Flow Margin of 12.07%. In addition the company used 21.63m on investing activities and also paid 1.88m in financing cash flows.
| Cash flow per share | 2.68 |
|---|---|
| Price/Cash flow per share | 67.57 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -74.60%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| EPS growth(5 years) | -14.29 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -56.71 |
